The Role of Risk Communication in the Care of Osteoporosis

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2011 Apr 21

PMID 21505788

Citations 8

Authors

E Michael Lewiecki

Affiliations

Soon will be listed here.

Abstract

Risk assessment and communication of risk are essential components in the care of patients with osteoporosis. The risk of fracture in an untreated patient can be estimated with measurement of bone mineral density, consideration of clinical risk factors, and the use of a validated fracture risk assessment algorithm. When fracture risk is high, pharmacologic therapy to reduce the risk of fracture is indicated, provided no contraindications are present. Initiation, compliance, and persistence with therapy may be enhanced when the patient fully understands the risk of fracture if no treatment is given, as well as the expected benefit and potential risks of treatment. Optimal clinical outcomes with treatment may in part depend on the clinician's skill in communicating risk with the patient, understanding the patient's concerns, and reaching a collaborative treatment decision that is medically reasonable and acceptable to the patient.

Citing Articles

Patient Perception on Osteoporosis in Korean Female Patients with Osteoporosis.

Lee K, Lee G, Lee T, Byun D, Ha Y J Bone Metab. 2024; 31(1):63-74.

PMID: 38485243 PMC: 10940108. DOI: 10.11005/jbm.2024.31.1.63.

Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.

Beaudart C, Sharma M, Clark P, Fujiwara S, Adachi J, Messina O Osteoporos Int. 2023; 35(3):451-468.

PMID: 37955683 PMC: 10866759. DOI: 10.1007/s00198-023-06955-9.

The clinician's guide to prevention and treatment of osteoporosis.

LeBoff M, Greenspan S, Insogna K, Lewiecki E, Saag K, Singer A Osteoporos Int. 2022; 33(10):2049-2102.

PMID: 35478046 PMC: 9546973. DOI: 10.1007/s00198-021-05900-y.

Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.

Beaudart C, Hiligsmann M, Li N, Lewiecki E, Silverman S Osteoporos Int. 2021; 33(1):13-26.

PMID: 34559256 PMC: 8758611. DOI: 10.1007/s00198-021-06151-7.

Romosozumab, clinical trials, and real-world care of patients with osteoporosis.

Lewiecki E Ann Transl Med. 2020; 8(15):974.

PMID: 32953774 PMC: 7475409. DOI: 10.21037/atm.2020.03.196.

References

Lewiecki E, Rudolph L, Kiebzak G, Chavez J, Thorpe B . Assessment of osteoporosis-website quality. Osteoporos Int. 2006; 17(5):741-52. DOI: 10.1007/s00198-005-0042-5. View

Wysowski D . Reports of esophageal cancer with oral bisphosphonate use. N Engl J Med. 2009; 360(1):89-90. DOI: 10.1056/NEJMc0808738. View

Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

Kanis J, Johansson H, Oden A, McCloskey E . Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone. 2009; 44(6):1049-54. DOI: 10.1016/j.bone.2009.02.014. View

Edwards A, Elwyn G . How should effectiveness of risk communication to aid patients' decisions be judged? A review of the literature. Med Decis Making. 1999; 19(4):428-34. DOI: 10.1177/0272989X9901900411. View

McCloskey E, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K . Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int. 2008; 20(5):811-7. DOI: 10.1007/s00198-008-0786-9. View

Galesic M, Garcia-Retamero R, Gigerenzer G . Using icon arrays to communicate medical risks: overcoming low numeracy. Health Psychol. 2009; 28(2):210-6. DOI: 10.1037/a0014474. View

Rothman A, Kiviniemi M . Treating people with information: an analysis and review of approaches to communicating health risk information. J Natl Cancer Inst Monogr. 2000; (25):44-51. DOI: 10.1093/oxfordjournals.jncimonographs.a024207. View

Foley K, Foster S, Meadows E, Baser O, Long S . Assessment of the clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure. Med Care. 2007; 45(9):902-6. DOI: 10.1097/MLR.0b013e3180536764. View

10.

Winzenberg T, Oldenburg B, Frendin S, De Wit L, Riley M, Jones G . The effect on behavior and bone mineral density of individualized bone mineral density feedback and educational interventions in premenopausal women: a randomized controlled trial [NCT00273260]. BMC Public Health. 2006; 6:12. PMC: 1386726. DOI: 10.1186/1471-2458-6-12. View

11.

OConnor A, Bennett C, Stacey D, Barry M, Col N, Eden K . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; (3):CD001431. DOI: 10.1002/14651858.CD001431.pub2. View

12.

Lipkus I, Samsa G, Rimer B . General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001; 21(1):37-44. DOI: 10.1177/0272989X0102100105. View

13.

Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L . Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int. 2006; 17(6):914-21. DOI: 10.1007/s00198-006-0073-6. View

14.

Whitney S . A new model of medical decisions: exploring the limits of shared decision making. Med Decis Making. 2003; 23(4):275-80. DOI: 10.1177/0272989X03256006. View

15.

Pencille L, Campbell M, Van Houten H, Shah N, Mullan R, Swiglo B . Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials. 2009; 10:113. PMC: 2796658. DOI: 10.1186/1745-6215-10-113. View

16.

Gaissmaier W, Gigerenzer G . Statistical illiteracy undermines informed shared decision making. Z Evid Fortbild Qual Gesundhwes. 2009; 102(7):411-3. DOI: 10.1016/j.zefq.2008.08.013. View

17.

Schapira M, Nattinger A, McHorney C . Frequency or probability? A qualitative study of risk communication formats used in health care. Med Decis Making. 2002; 21(6):459-67. DOI: 10.1177/0272989X0102100604. View

18.

Lloyd A, Hayes P, London N, Bell P, Naylor A . Patients' ability to recall risk associated with treatment options. Lancet. 1999; 353(9153):645. DOI: 10.1016/s0140-6736(98)05670-0. View

19.

Sambrook P, Chen J, Simpson J, March L . Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust. 2010; 193(3):154-6. DOI: 10.5694/j.1326-5377.2010.tb03835.x. View

20.

Khosla S, Burr D, Cauley J, Dempster D, Ebeling P, Felsenberg D . Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22(10):1479-91. DOI: 10.1359/jbmr.0707onj. View